Arrow International, Inc.
$1.1M 184 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Medartis Inc.
Medartis Inc. reported $1,123,845.45 across General Payments, Research, and Ownership to 504 physicians and teaching hospitals across 515 transactions.
- $1.1M Above-median payer
- All-tracks total
- 515 Above-median volume
- Transactions
- 504 Above-median reach
- Recipients
- +$66.5K
- General Payments vs PY2023
Medartis Inc. reported $1,123,845.45 across all CMS Open Payments tracks (General + Research + Ownership) to 504 physicians and teaching hospitals in Program Year 2024 - ranking #594 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,041,032.79, averaging $2.2K per recipient.
How Medartis Inc.'s $1.1M all-tracks total breaks down
Medartis Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
31/100
Total payments
F
20/100
Transaction volume
F
14/100
Physician reach
F
14/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer medartis-inc Medartis Inc.
$1.1M · #594/1,925 · 0.0% industry · PY2024
- TOT $1.1M
- RANK #594
- SHARE 0.0%
- TXN 515
- RCP 504
- CAT 6
- GEN $1.0M
- ΔGEN +$66.5K
- TOP1 12.7%
- PY 2024
Volume peers
Nearest volume peer: Arrow International, Inc. ($1.1M)
Medartis Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Medartis Inc.'s CMS-reported General Payments increased by $66.5K (+6.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MEDARTIS INC.PY2023: MEDARTIS INC.PY2024: Medartis Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $974,574.99
- PY2024
- $1,041,032.79
What the Data Shows for Medartis Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Medartis Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 6 general-payment categories charted below, "Royalty or License" is the largest at $774.2K across 89 transactions, 74.4% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Medartis Inc. made 6 types of general payments. "Royalty or License" is the largest category at $774.2K, 74.4% of General Payments.
Medartis Inc. reports 6 general-payment categories - the top three are Royalty or License (74.4%), Consulting Fee (11.6%), and Travel and Lodging (8.6%). The remaining 3 categories make up 5.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Medartis Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $774.2K | 89 | 74.4% |
| Consulting Fee | $120.4K | 28 | 11.6% |
| Travel and Lodging | $89.9K | 47 | 8.6% |
| Food and Beverage | $35.4K | 332 | 3.4% |
| Compensation for Services Other Than Consulting | $19.0K | 7 | 1.8% |
| Honoraria | $2.2K | 1 | 0.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $489,874.38 (47.1%) of $1,041,032.79 in this company's General Payments records across 264 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Medartis Inc.
The five named recipients with the highest reported General Payments from this company
- 1
John Anderson
$132,164.63 across 5 reported transactions
- 2
Brett Sachs
$125,988.49 across 5 reported transactions
- 3
Thomas Mcdonald
$125,573.10 across 5 reported transactions
- 4
Graham Hamilton
$53,555.16 across 7 reported transactions
- 5
William Geissler
$52,593.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Medartis Inc. ranks #594 of 1,925 by total payments (top 31% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,193 of 1,838 by HHI (bottom 35% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Nexus Medical Technologies Llc : $4.1K total payments, HHI 667
- Sonex Health, Inc. : $428.3K total payments, HHI 666
- Xtant Medical Inc : $659.3K total payments, HHI 666
- Acella Pharmaceuticals, LLC : $103.8K total payments, HHI 660
- Ortho Solutions Inc : $57.2K total payments, HHI 656
- Endomagnetics Ltd : $228.3K total payments, HHI 655
- Medartis Inc. (this company) : $1.0M total payments, HHI 655
- KARL STORZ Endoscopy-America : $1.4M total payments, HHI 655
- Advanced Critical Devices, Inc. : $1.2K total payments, HHI 653
- BioLineRx USA, Inc. : $112.3K total payments, HHI 652
- Cardinal Health 108 LLC : $1.8K total payments, HHI 651
- ADMA BioManufacturing LLC : $167.7K total payments, HHI 650
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Medartis Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Medartis Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Medartis Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Guard Medical SAS
$1.1M 0 recipients
Compare payment profiles
Avanos Medical
$1.1M 3,846 recipients
Compare payment profiles
Fisher & Paykel Healthcare Limited
$1.1M 25 recipients
Compare payment profiles
Avid Radiopharmaceuticals, Inc.
$1.1M 38 recipients
Compare payment profiles
Gynesonics, Inc.
$1.1M 2,114 recipients
Compare payment profiles
Put this to use
Medartis Inc. ranks #594 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See where Medartis Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Medartis Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.